TrialRMD open2022

Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2.

Andrew J K Ostor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.